Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 08 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-0.11 Insider Own4.18% Shs Outstand221.82M Perf Week-2.62%
Market Cap838.35M Forward P/E22.83 EPS next Y0.16 Insider Trans-20.45% Shs Float216.53M Perf Month2.49%
Income-22.83M PEG- EPS next Q0.01 Inst Own76.88% Short Float / Ratio4.29% / 5.16 Perf Quarter-2.88%
Sales234.29M P/S3.58 EPS this Y91.67% Inst Trans7.73% Short Interest9.28M Perf Half Y-2.88%
Book/sh0.67 P/B5.54 EPS next Y690.91% ROA-7.03% Target Price6.00 Perf Year7.54%
Cash/sh0.33 P/C11.30 EPS next 5Y- ROE-18.13% 52W Range2.94 - 4.65 Perf YTD-4.38%
Dividend- P/FCF- EPS past 5Y29.48% ROI-7.52% 52W High-20.22% Beta0.51
Dividend %- Quick Ratio2.64 Sales past 5Y54.67% Gross Margin30.44% 52W Low25.98% ATR0.14
Employees617 Current Ratio6.54 Sales Q/Q63.72% Oper. Margin0.57% RSI (14)47.96 Volatility2.86% 3.68%
OptionableYes Debt/Eq1.01 EPS Q/Q114.49% Profit Margin-9.74% Rel Volume0.61 Prev Close3.77
ShortableYes LT Debt/Eq1.00 EarningsNov 08 AMC Payout- Avg Volume1.80M Price3.71
Recom1.00 SMA20-3.45% SMA504.15% SMA2001.39% Volume1,099,290 Change-1.59%
Date Action Analyst Rating Change Price Target Change
Jul-19-23Resumed Raymond James Strong Buy $5
Oct-13-22Initiated Mizuho Buy $5
Nov-11-21Upgrade Raymond James Outperform → Strong Buy $5
Nov-09-21Initiated Cantor Fitzgerald Overweight $4.50
Jun-04-19Initiated Jefferies Buy $8
Apr-15-19Reiterated H.C. Wainwright Buy $10 → $13
Feb-07-19Resumed H.C. Wainwright Buy $10
Dec-11-17Reiterated Maxim Group Buy $13 → $8
Nov-14-17Upgrade Raymond James Mkt Perform → Outperform
Jan-23-17Upgrade Maxim Group Hold → Buy $13
Today 09:30AM
Dec-06-23 09:40AM
Nov-22-23 09:30AM
Nov-17-23 06:29PM
Nov-16-23 07:00AM
11:05AM Loading…
Nov-10-23 11:05AM
Nov-09-23 04:25PM
Nov-08-23 04:49PM
Nov-06-23 09:30AM
Nov-02-23 05:45PM
Nov-01-23 07:00AM
Oct-27-23 05:45PM
Oct-25-23 05:50PM
05:50PM Loading…
Oct-17-23 05:50PM
Oct-09-23 05:50PM
Sep-29-23 09:30AM
Sep-27-23 05:50PM
Sep-21-23 05:50PM
Sep-14-23 05:50PM
Sep-13-23 09:30AM
Aug-10-23 02:31PM
Aug-09-23 06:40PM
Aug-02-23 07:00AM
08:59AM Loading…
Jul-28-23 08:59AM
Jul-26-23 11:30AM
Jul-25-23 05:12PM
Jul-20-23 05:50PM
Jul-19-23 07:00AM
Jul-13-23 05:50PM
Jul-07-23 07:32AM
Jun-23-23 10:31AM
Jun-22-23 09:18AM
Jun-21-23 03:21PM
Jun-19-23 10:28AM
Jun-16-23 10:43AM
Jun-14-23 12:17PM
Jun-13-23 09:18AM
Jun-08-23 11:49AM
Jun-07-23 12:31PM
Jun-06-23 11:14AM
Jun-05-23 12:43PM
Jun-02-23 10:59AM
Jun-01-23 11:59AM
May-31-23 10:46AM
May-30-23 10:56AM
May-29-23 09:40AM
May-26-23 08:23AM
May-25-23 03:16PM
May-24-23 11:37AM
May-22-23 11:05AM
May-18-23 11:15AM
May-17-23 02:19PM
May-12-23 09:40AM
May-11-23 09:35AM
May-10-23 05:15PM
May-03-23 11:55AM
May-02-23 07:00AM
Apr-18-23 11:43AM
Apr-17-23 03:25PM
Apr-12-23 10:42AM
Mar-27-23 07:08AM
Mar-26-23 09:22AM
Mar-24-23 09:37AM
Mar-23-23 05:45PM
Mar-16-23 07:00AM
Mar-03-23 09:48AM
Mar-01-23 09:36AM
Feb-28-23 09:10AM
Feb-19-23 02:05PM
Feb-12-23 10:56AM
Feb-08-23 07:00AM
Feb-07-23 10:17AM
Jan-17-23 07:00AM
Dec-28-22 11:58PM
Dec-13-22 07:00AM
Dec-11-22 08:41AM
Dec-09-22 04:05PM
Dec-07-22 08:45AM
Dec-06-22 04:05PM
ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Grossman Jerrold BDirectorAug 30Buy3.71130,000482,144443,265Aug 30 04:58 PM
KWON YOUNGDirectorAug 24Buy3.9025,00097,500277,401Aug 24 07:53 PM
Fong BryantDirectorAug 22Sale3.871,433,3045,544,7370Aug 23 08:30 PM
Grossman Adam SPresident and CEOAug 18Sale4.15250,0001,038,3502,273,085Aug 18 09:46 PM
LENZ BRIANEVP, CFOAug 16Sale4.45178,184793,400782,013Aug 17 09:30 PM
Grossman Adam SPresident and CEOAug 16Sale4.383132,523,085Aug 17 09:30 PM
Grossman Adam SPresident and CEOAug 15Option Exercise3.112,100,4596,536,4484,623,544Aug 17 09:30 PM
LENZ BRIANEVP, CFOAug 15Option Exercise3.11809,2622,514,3631,591,275Aug 17 09:30 PM
Grossman Adam SPresident and CEOAug 15Sale4.54510,4692,318,9594,113,075Aug 17 09:30 PM
LENZ BRIANEVP, CFOAug 15Sale4.60211,578972,730782,013Aug 17 09:30 PM
Grossman Adam SPresident and CEODec 09Buy2.8614,98342,8512,203,708Dec 09 04:41 PM
Grossman Adam SPresident and CEODec 09Buy2.8614,98242,8491,143,426Dec 09 04:41 PM
LENZ BRIANEVP, CFODec 09Buy2.866,99320,0001,034,825Dec 09 04:41 PM